Effects of Oral Cholecalciferol (Vitamin D3) on Bone Health, Neuromuscular Function, and Quality of Life in Adults With Chronic Kidney Disease (Neph)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00511225|
Recruitment Status : Completed
First Posted : August 3, 2007
Last Update Posted : July 3, 2012
Dialysis Clinic, Inc.
Information provided by (Responsible Party):
Laura Armas, Creighton University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||June 2010|
|Actual Study Completion Date :||September 2011|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Graeff-Armas LA, Kaufmann M, Lyden E, Jones G. Serum 24,25-dihydroxyvitamin D(3) response to native vitamin D(2) and D(3) Supplementation in patients with chronic kidney disease on hemodialysis. Clin Nutr. 2018 Jun;37(3):1041-1045. doi: 10.1016/j.clnu.2017.04.020. Epub 2017 Apr 30.